RMD Open (Nov 2020)

Cigarette smoking patterns preceding primary Sjögren’s syndrome

  • Marika Kvarnström,
  • Lars Alfredsson,
  • Leonid Padyukov,
  • Johannes Mofors,
  • Marie Wahren-Herlenius,
  • Jan Hillert,
  • Ingrid Kockum,
  • Thomas Mandl,
  • Gunnel Nordmark,
  • Albin Björk,
  • Sara Magnusson-Bucher,
  • Per Eriksson,
  • Elina Richardsdotter Andersson,
  • Helena Forsblad d’Elia

DOI
https://doi.org/10.1136/rmdopen-2020-001402
Journal volume & issue
Vol. 6, no. 3

Abstract

Read online

Background Cigarette smoking is a well-established risk factor for several autoimmune diseases, but its role in primary Sjögren’s syndrome (pSS) remains unclear. Here, we investigated the association between cigarette smoking and subsequent development of pSS.Methods Information on smoking habits was collected from lifestyle habit questionnaires of patients with pSS (n=815) and a matched control group (n=4425) for a case–control study. Differences in smoking exposure were analysed by conditional logistic regression. Potential interactions between smoking and risk-associated human leucocyte antigens (HLA) were assessed by multivariate regression.Results The fraction of patients with pSS having ever smoked prior to diagnosis was lower than in controls (OR 0.67, 95% CI 0.55 to 0.81). Current smoking at diagnosis was also less prevalent in cases (OR 0.37, 95% CI 0.26 to 0.53). However, period prevalence of smoking during early adulthood was not statistically different from controls (OR 0.89, 95% CI 0.66 to 1.22) but markedly decreased over time. This was partly due to patients being more prone to stop smoking, starting already 30 years prior to diagnosis (OR 2.01, 95% CI 1.22 to 3.30). Smoking patterns were also stratified by autoantibody status, yielding similar estimates. No interaction effects between HLA-DRB1 haplotypes and smoking were observed.Conclusion The observed smoking patterns indicate that individuals who develop pSS smoke equally much as the general population during early life but are then more prone to stop. The data can be interpreted as smoking conferring protective effects, or reflecting early symptoms of pSS that affect smoking habits, emphasising the slow, progressive development of the disease.